Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04824625
Other study ID # StJordi-CoV
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 27, 2021
Est. completion date April 10, 2021

Study information

Verified date April 2021
Source Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

From the beginning of the pandemic caused by SARS-CoV-2, most events with massive participants have been canceled due to being considered high-risk events for the SARS-CoV-2 transmission. It has been detected that asymptomatic people infected by SARS-CoV-2, are playing an important role in the contagious in these kinds of events. The economic losses arising from the closure of these activities, mainly those related to culture and musical performances are around 2.5 billion euros a Catalonia, and a considerable loss of jobs in this sector. Developing strategies of cribrate of infected people by SARS-CoV-2 asymptomatic or not diagnosticated and with a potential transmission of the virus is the key to perform cultural, sport, etc. massive events with all the security. The objective is to exclude infected people with a a high potential of transmission. It is needed to use versatile tests for this objective, so the test must have a high sensibility to detect infected people, the test has to be easy to manipulate without requiring a high technology of the laboratory hospitals, neither prolongated to obtain a result and that has a low cost. The rapid SARS-CoV-2 antigen screening tests are best suited for this purpose. On 27th March, a musical concert will be performed at Palau St Jordi (Barcelona) with 5000 attendees and with all the SARS-COV-2 safety measures by the "Secretary General of Health of the Generalitat de Catalunya" a (mandatory wearing a mask during the event, restricted outdoor areas of bar and smoking enhanced ventilation of the whole indoor area and avoiding queues.). This study wants to assess the incidence of SARS-CoV-2 infection reported to the health system among the attendees of this commercial concert during the 14 days following the event, also it will be evaluated the clinical evolution of the possible infections during the concert.


Description:

From the beginning of the pandemic caused by SARS-CoV-2, most events with massive participants have been canceled due to being considered high-risk events for the SARS-CoV-2 transmission. It has been detected that asymptomatic people infected by SARS-CoV-2, are playing an important role in the contagious in these kinds of events. The economic losses arising from the closure of these activities, mainly those related to culture and musical performances are around 2.5 billion euros a Catalonia, and a considerable loss of jobs in this sector. Developing strategies of cribrate of infected people by SARS-CoV-2 asymptomatic or not diagnosticated and with a potential transmission of the virus is the key to perform cultural, sport, etc. massive events with all the security. The objective is to exclude infected people with a a high potential of transmission. It is needed to use versatile tests for this objective, so the test must have a high sensibility to detect infected people, the test has to be easy to manipulate without requiring a high technology of the laboratory hospitals, neither prolongated to obtain a result and that has a low cost. The rapid SARS-CoV-2 antigen screening tests are best suited for this purpose. These tests have shown a sensitivity close to 99% to detect infectious people who have a high viral load of SARS-CoV-2. No viral isolation has been demonstrated in any culture of samples of patients infected with SARS-CoV-2 with a Ct threshold (cycle threshold) in the test RT-PCR greater than 30, which is considered to delimit the transmitting potential of the infected On 27th March, a musical concert will be performed at Palau St Jordi (Barcelona) with 5000 attendees and with all the SARS-COV-2 safety measures by the Secretaria General de Salut de la Generalitat de Catalunya (mandatory wearing a mask during the event, restricted outdoor areas of bar and smoking enhanced ventilation of the whole indoor area and avoiding queues.). This study wants to assess the incidence of SARS-CoV-2 infection reported to the health system among the attendees of this commercial concert during the 14 days following the event, also it will be evaluated the clinical evolution of the possible infections during the concert.


Recruitment information / eligibility

Status Completed
Enrollment 5000
Est. completion date April 10, 2021
Est. primary completion date March 27, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Adults (> 18 years and under 65) attending the commercial music event scheduled at the Palau Sant Jordi - Sign informed consent, including an authorization for the collection of data from the electronic health system of the Catalan System of Health on the notification of COVID-19 infection during the 14 days following the event or authorization to be contacted by telephone by the medical team, if necessary, for complete information on SARS-CoV-2 infection. Exclusion Criteria: - Minors (<18 years)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Germans Trias i Pujol Hospital Badalona Barcelona

Sponsors (2)

Lead Sponsor Collaborator
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia Festivals per la Cultura Segura AIE

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence rate of people with SARS-CoV-2 Incidence rate of assistants with reported SARS-COV-2 14 dys after the event From day 1 to day 14 after the event
Primary Incidence rate of consultations in primary care centers Incidence rate of consultations in primary care centers about symptoms compatible with COVID-19 during the 14 days after the event From day 1 to day 14 after the event
Secondary Incidence rate of Hospital emergencies Incidence rate of hospital emergencies about symptoms compatible with COVID-19 during the 14 days after the event From day 1 to day 14 after the event
Secondary Incidence rate of hospital admissions Incidence rate of hospital admissions about symptoms compatible with COVID-19 during the 14 days after the event From day 1 to day 14 after the event
Secondary Incidence rate of Intensive care units admissions Incidence rate of intensive care units in the concert participants with COVID-19 during the 14 days after the event From day 1 to day 14 after the event
Secondary Incidence rate of mortality Incidence rate of COVID-19 mortality in the concert participants during the 14 days after the event From day 1 to day 14 after the event
See also
  Status Clinical Trial Phase
Completed NCT04668625 - Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures N/A
Completed NCT04476602 - Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol